phase readout
saveNCT04848506: Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
ENROLLING_BY_INVITATIONupdated 20d ago
community read0 votes
Sponsor: Cytokinetics. Phase: PHASE2. Conditions: Symptomatic Hypertrophic Cardiomyopathy (HCM)
view source ↗
comments(0)
5-min edit window · permanent after that